25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Atrys Health SL
Buy, Hold or Sell?

Let's analyze Atrys Health SL together

I guess you are interested in Atrys Health SL. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Atrys Health SL. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Atrys Health SL

I send you an email if I find something interesting about Atrys Health SL.

1. Quick Overview

1.1. Quick analysis of Atrys Health SL (30 sec.)










1.2. What can you expect buying and holding a share of Atrys Health SL? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€3.57
Expected worth in 1 year
€2.95
How sure are you?
52.9%

+ What do you gain per year?

Total Gains per Share
€-0.62
Return On Investment
-20.1%

For what price can you sell your share?

Current Price per Share
€3.07
Expected price per share
€3 - €3.95
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Atrys Health SL (5 min.)




Live pricePrice per Share (EOD)
€3.07
Intrinsic Value Per Share
€-8.88 - €-10.53
Total Value Per Share
€-5.31 - €-6.96

2.2. Growth of Atrys Health SL (5 min.)




Is Atrys Health SL growing?

Current yearPrevious yearGrowGrow %
How rich?$288.9m$349m-$48.2m-16.0%

How much money is Atrys Health SL making?

Current yearPrevious yearGrowGrow %
Making money-$12.7m-$15.8m$3.1m24.6%
Net Profit Margin-19.3%-17.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Atrys Health SL (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#193 / 959

Most Revenue
#114 / 959

Most Profit
#614 / 959

Most Efficient
#355 / 959
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Atrys Health SL?

Welcome investor! Atrys Health SL's management wants to use your money to grow the business. In return you get a share of Atrys Health SL.

First you should know what it really means to hold a share of Atrys Health SL. And how you can make/lose money.

Speculation

The Price per Share of Atrys Health SL is €3.07. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Atrys Health SL.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Atrys Health SL, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €3.57. Based on the TTM, the Book Value Change Per Share is €-0.15 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Atrys Health SL.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.12-3.8%-0.17-5.5%-0.19-6.1%-0.09-3.0%-0.05-1.7%
Usd Book Value Change Per Share0.000.0%-0.16-5.4%-0.09-3.0%0.175.6%0.113.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%-0.16-5.4%-0.09-3.0%0.175.6%0.113.6%
Usd Price Per Share3.77-3.82-6.06-6.83-4.84-
Price to Earnings Ratio-8.16--6.77--8.65--147.97--11.05-
Price-to-Total Gains Ratio92,172.93-23,048.57-100.86--19,181,698.94--25,324,884.37-
Price to Book Ratio0.99-0.96-1.32-4.00-5.04-
Price-to-Total Gains Ratio92,172.93-23,048.57-100.86--19,181,698.94--25,324,884.37-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.27262
Number of shares305
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.160.17
Usd Total Gains Per Share-0.160.17
Gains per Quarter (305 shares)-50.1452.31
Gains per Year (305 shares)-200.57209.22
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-201-2110209199
20-401-4120418408
30-602-6130628617
40-802-8140837826
50-1003-1015010461035
60-1203-1216012551244
70-1404-1417014651453
80-1605-1618016741662
90-1805-1819018831871
100-2006-2020020922080

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%10.024.00.029.4%10.024.00.029.4%
Book Value Change Per Share2.02.00.050.0%4.05.03.033.3%8.08.04.040.0%18.012.04.052.9%18.012.04.052.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.034.00.0%0.00.034.00.0%
Total Gains per Share2.02.00.050.0%4.05.03.033.3%8.08.04.040.0%18.012.04.052.9%18.012.04.052.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Atrys Health SL compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.000-0.154+401657%-0.086+224897%0.161-100%0.105-100%
Book Value Per Share--3.5703.715-4%4.312-17%2.996+19%1.864+91%
Current Ratio--0.9790.976+0%0.995-2%1.288-24%1.552-37%
Debt To Asset Ratio--0.5500.542+2%0.532+3%0.536+3%0.538+2%
Debt To Equity Ratio--1.2241.191+3%1.139+7%1.165+5%1.269-4%
Dividend Per Share----0%-0%-0%-0%
Eps---0.109-0.158+45%-0.175+61%-0.085-21%-0.050-54%
Free Cash Flow Per Share---0.129-0.066-49%-0.123-5%-0.058-55%-0.041-69%
Free Cash Flow To Equity Per Share---0.122-0.003-98%-0.110-10%0.117-204%0.086-243%
Gross Profit Margin--1.0151.009+1%1.0200%1.032-2%1.0190%
Intrinsic Value_10Y_max---10.534--------
Intrinsic Value_10Y_min---8.876--------
Intrinsic Value_1Y_max---0.464--------
Intrinsic Value_1Y_min---0.456--------
Intrinsic Value_3Y_max---1.846--------
Intrinsic Value_3Y_min---1.753--------
Intrinsic Value_5Y_max---3.771--------
Intrinsic Value_5Y_min---3.461--------
Market Cap233096798.720-15%268827925.680272060810.453-1%431646677.760-38%486400512.683-45%344756822.653-22%
Net Profit Margin---0.151-0.193+28%-0.178+18%-0.143-5%-0.076-50%
Operating Margin---0.0140.000-98%0.000-5415%0.002-984%0.016-188%
Operating Ratio--0.7930.968-18%1.051-24%1.042-24%0.987-20%
Pb Ratio0.860-15%0.9920.963+3%1.317-25%3.996-75%5.039-80%
Pe Ratio-7.074+13%-8.157-6.766-17%-8.647+6%-147.968+1714%-11.051+35%
Price Per Share3.070-15%3.5403.583-1%5.685-38%6.406-45%4.541-22%
Price To Free Cash Flow Ratio-5.941+13%-6.8501.715-499%-15.227+122%2.354-391%-12.168+78%
Price To Total Gains Ratio79935.283-15%92172.93223048.573+300%100.856+91290%-19181698.938+20911%-25324884.372+27575%
Quick Ratio--0.7680.716+7%0.873-12%1.157-34%1.411-46%
Return On Assets---0.014-0.019+41%-0.021+56%-0.014-1%-0.007-47%
Return On Equity---0.030-0.042+39%-0.046+50%-0.029-3%-0.014-53%
Total Gains Per Share--0.000-0.154+401657%-0.086+224897%0.161-100%0.105-100%
Usd Book Value--288989402.000300777230.000-4%349033184.500-17%242536832.480+19%150901593.607+92%
Usd Book Value Change Per Share--0.000-0.164+401657%-0.092+224897%0.171-100%0.112-100%
Usd Book Value Per Share--3.8053.961-4%4.597-17%3.194+19%1.987+91%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.116-0.168+45%-0.187+61%-0.091-21%-0.053-54%
Usd Free Cash Flow---10458526.000-5340127.000-49%-9939783.750-5%-4686601.789-55%-2902734.523-72%
Usd Free Cash Flow Per Share---0.138-0.070-49%-0.131-5%-0.062-55%-0.043-69%
Usd Free Cash Flow To Equity Per Share---0.130-0.003-98%-0.117-10%0.125-204%0.091-243%
Usd Market Cap248481187.436-15%286570568.775290016823.942-1%460135358.492-38%518502946.520-45%367510772.948-22%
Usd Price Per Share3.273-15%3.7743.819-1%6.060-38%6.829-45%4.840-22%
Usd Profit---8783307.000-12758154.500+45%-15899656.500+81%-8145841.292-7%-4773946.653-46%
Usd Revenue--58289946.00063468174.250-8%86425683.500-33%49508519.211+18%30235637.763+93%
Usd Total Gains Per Share--0.000-0.164+401657%-0.092+224897%0.171-100%0.112-100%
 EOD+2 -6MRQTTM+18 -16YOY+14 -205Y+9 -2510Y+9 -25

3.3 Fundamental Score

Let's check the fundamental score of Atrys Health SL based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.074
Price to Book Ratio (EOD)Between0-10.860
Net Profit Margin (MRQ)Greater than0-0.151
Operating Margin (MRQ)Greater than0-0.014
Quick Ratio (MRQ)Greater than10.768
Current Ratio (MRQ)Greater than10.979
Debt to Asset Ratio (MRQ)Less than10.550
Debt to Equity Ratio (MRQ)Less than11.224
Return on Equity (MRQ)Greater than0.15-0.030
Return on Assets (MRQ)Greater than0.05-0.014
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Atrys Health SL based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.598
Ma 20Greater thanMa 503.224
Ma 50Greater thanMa 1003.252
Ma 100Greater thanMa 2003.350
OpenGreater thanClose3.030
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Atrys Health SL

Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. The company offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics; and diagnostic second opinion, test directory, and clinical trials and R&D services. It uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology. The company also provides radiotherapy; and develops therapeutic modalities and diagnostic tools. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. The company was incorporated in 2007 and is headquartered in Madrid, Spain.

Fundamental data was last updated by Penke on 2024-11-13 07:47:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Atrys Health SL earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Atrys Health SL to the Biotechnology industry mean.
  • A Net Profit Margin of -15.1% means that €-0.15 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Atrys Health SL:

  • The MRQ is -15.1%. The company is making a huge loss. -2
  • The TTM is -19.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-15.1%TTM-19.3%+4.2%
TTM-19.3%YOY-17.8%-1.4%
TTM-19.3%5Y-14.3%-5.0%
5Y-14.3%10Y-7.6%-6.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.1%-133.6%+118.5%
TTM-19.3%-204.9%+185.6%
YOY-17.8%-207.4%+189.6%
5Y-14.3%-353.5%+339.2%
10Y-7.6%-466.1%+458.5%
4.3.1.2. Return on Assets

Shows how efficient Atrys Health SL is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Atrys Health SL to the Biotechnology industry mean.
  • -1.4% Return on Assets means that Atrys Health SL generated €-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Atrys Health SL:

  • The MRQ is -1.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.4%TTM-1.9%+0.6%
TTM-1.9%YOY-2.1%+0.2%
TTM-1.9%5Y-1.4%-0.6%
5Y-1.4%10Y-0.7%-0.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.4%-10.8%+9.4%
TTM-1.9%-11.8%+9.9%
YOY-2.1%-11.0%+8.9%
5Y-1.4%-12.6%+11.2%
10Y-0.7%-14.4%+13.7%
4.3.1.3. Return on Equity

Shows how efficient Atrys Health SL is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Atrys Health SL to the Biotechnology industry mean.
  • -3.0% Return on Equity means Atrys Health SL generated €-0.03 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Atrys Health SL:

  • The MRQ is -3.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.0%TTM-4.2%+1.2%
TTM-4.2%YOY-4.6%+0.3%
TTM-4.2%5Y-2.9%-1.3%
5Y-2.9%10Y-1.4%-1.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.0%-13.5%+10.5%
TTM-4.2%-15.9%+11.7%
YOY-4.6%-13.5%+8.9%
5Y-2.9%-18.6%+15.7%
10Y-1.4%-19.0%+17.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Atrys Health SL.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Atrys Health SL is operating .

  • Measures how much profit Atrys Health SL makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Atrys Health SL to the Biotechnology industry mean.
  • An Operating Margin of -1.4% means the company generated €-0.01  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Atrys Health SL:

  • The MRQ is -1.4%. The company is operating very inefficient. -2
  • The TTM is 0.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1.4%TTM0.0%-1.4%
TTM0.0%YOY0.0%-0.1%
TTM0.0%5Y0.2%-0.2%
5Y0.2%10Y1.6%-1.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.4%-277.1%+275.7%
TTM0.0%-312.9%+312.9%
YOY0.0%-222.0%+222.0%
5Y0.2%-385.5%+385.7%
10Y1.6%-495.6%+497.2%
4.3.2.2. Operating Ratio

Measures how efficient Atrys Health SL is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.79 means that the operating costs are €0.79 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Atrys Health SL:

  • The MRQ is 0.793. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.968. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.793TTM0.968-0.175
TTM0.968YOY1.051-0.082
TTM0.9685Y1.042-0.074
5Y1.04210Y0.987+0.055
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7932.842-2.049
TTM0.9683.198-2.230
YOY1.0513.301-2.250
5Y1.0424.800-3.758
10Y0.9876.530-5.543
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Atrys Health SL.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Atrys Health SL is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.98 means the company has €0.98 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Atrys Health SL:

  • The MRQ is 0.979. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.976. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.979TTM0.976+0.003
TTM0.976YOY0.995-0.019
TTM0.9765Y1.288-0.312
5Y1.28810Y1.552-0.264
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9793.788-2.809
TTM0.9763.923-2.947
YOY0.9954.711-3.716
5Y1.2885.959-4.671
10Y1.5526.278-4.726
4.4.3.2. Quick Ratio

Measures if Atrys Health SL is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Atrys Health SL to the Biotechnology industry mean.
  • A Quick Ratio of 0.77 means the company can pay off €0.77 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Atrys Health SL:

  • The MRQ is 0.768. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.716. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.768TTM0.716+0.051
TTM0.716YOY0.873-0.157
TTM0.7165Y1.157-0.441
5Y1.15710Y1.411-0.254
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7683.381-2.613
TTM0.7163.526-2.810
YOY0.8734.682-3.809
5Y1.1575.922-4.765
10Y1.4116.458-5.047
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Atrys Health SL.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Atrys Health SL assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Atrys Health SL to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.55 means that Atrys Health SL assets are financed with 55.0% credit (debt) and the remaining percentage (100% - 55.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Atrys Health SL:

  • The MRQ is 0.550. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.542. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.550TTM0.542+0.008
TTM0.542YOY0.532+0.010
TTM0.5425Y0.536+0.006
5Y0.53610Y0.538-0.002
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5500.338+0.212
TTM0.5420.347+0.195
YOY0.5320.310+0.222
5Y0.5360.365+0.171
10Y0.5380.381+0.157
4.5.4.2. Debt to Equity Ratio

Measures if Atrys Health SL is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Atrys Health SL to the Biotechnology industry mean.
  • A Debt to Equity ratio of 122.4% means that company has €1.22 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Atrys Health SL:

  • The MRQ is 1.224. The company is able to pay all its debts with equity. +1
  • The TTM is 1.191. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.224TTM1.191+0.033
TTM1.191YOY1.139+0.052
TTM1.1915Y1.165+0.026
5Y1.16510Y1.269-0.103
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2240.387+0.837
TTM1.1910.437+0.754
YOY1.1390.375+0.764
5Y1.1650.450+0.715
10Y1.2690.489+0.780
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Atrys Health SL generates.

  • Above 15 is considered overpriced but always compare Atrys Health SL to the Biotechnology industry mean.
  • A PE ratio of -8.16 means the investor is paying €-8.16 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Atrys Health SL:

  • The EOD is -7.074. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.157. Based on the earnings, the company is expensive. -2
  • The TTM is -6.766. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.074MRQ-8.157+1.083
MRQ-8.157TTM-6.766-1.391
TTM-6.766YOY-8.647+1.881
TTM-6.7665Y-147.968+141.202
5Y-147.96810Y-11.051-136.917
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.074-2.384-4.690
MRQ-8.157-2.428-5.729
TTM-6.766-2.991-3.775
YOY-8.647-3.440-5.207
5Y-147.968-6.006-141.962
10Y-11.051-6.278-4.773
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Atrys Health SL:

  • The EOD is -5.941. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.850. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 1.715. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-5.941MRQ-6.850+0.909
MRQ-6.850TTM1.715-8.566
TTM1.715YOY-15.227+16.942
TTM1.7155Y2.354-0.639
5Y2.35410Y-12.168+14.523
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.941-3.160-2.781
MRQ-6.850-3.222-3.628
TTM1.715-3.516+5.231
YOY-15.227-4.582-10.645
5Y2.354-8.076+10.430
10Y-12.168-8.950-3.218
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Atrys Health SL is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.99 means the investor is paying €0.99 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Atrys Health SL:

  • The EOD is 0.860. Based on the equity, the company is cheap. +2
  • The MRQ is 0.992. Based on the equity, the company is cheap. +2
  • The TTM is 0.963. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.860MRQ0.992-0.132
MRQ0.992TTM0.963+0.029
TTM0.963YOY1.317-0.353
TTM0.9635Y3.996-3.033
5Y3.99610Y5.039-1.042
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.8601.964-1.104
MRQ0.9921.983-0.991
TTM0.9632.197-1.234
YOY1.3172.404-1.087
5Y3.9963.596+0.400
10Y5.0394.223+0.816
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets603,063
Total Liabilities331,966
Total Stockholder Equity271,193
 As reported
Total Liabilities 331,966
Total Stockholder Equity+ 271,193
Total Assets = 603,063

Assets

Total Assets603,063
Total Current Assets93,182
Long-term Assets509,881
Total Current Assets
Cash And Cash Equivalents 12,081
Short-term Investments 724
Net Receivables 59,537
Inventory 1,577
Other Current Assets 17,627
Total Current Assets  (as reported)93,182
Total Current Assets  (calculated)91,546
+/- 1,636
Long-term Assets
Property Plant Equipment 59,637
Goodwill 273,532
Intangible Assets 143,099
Long-term Assets Other 24,079
Long-term Assets  (as reported)509,881
Long-term Assets  (calculated)500,347
+/- 9,534

Liabilities & Shareholders' Equity

Total Current Liabilities95,195
Long-term Liabilities236,771
Total Stockholder Equity271,193
Total Current Liabilities
Short-term Debt 47,356
Accounts payable 19,880
Other Current Liabilities 27,496
Total Current Liabilities  (as reported)95,195
Total Current Liabilities  (calculated)94,732
+/- 463
Long-term Liabilities
Long-term Liabilities  (as reported)236,771
Long-term Liabilities  (calculated)0
+/- 236,771
Total Stockholder Equity
Common Stock760
Retained Earnings -77,957
Accumulated Other Comprehensive Income -71,390
Other Stockholders Equity 404,061
Total Stockholder Equity (as reported)271,193
Total Stockholder Equity (calculated)255,474
+/- 15,719
Other
Cash and Short Term Investments 12,805
Common Stock Shares Outstanding 75,940
Current Deferred Revenue463
Liabilities and Stockholders Equity 603,063
Net Debt 238,237
Net Working Capital -2,013
Short Long Term Debt Total 250,318



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
> Total Assets 
25,416
15,501
30,569
30,569
30,441
30,441
40,585
40,197
37,529
37,529
53,693
53,693
60,045
60,045
88,043
88,043
90,607
90,607
180,971
175,776
556,524
556,524
565,632
565,632
697,102
697,102
704,048
705,281
695,477
695,477
629,001
629,001
603,063
603,063
603,063603,063629,001629,001695,477695,477705,281704,048697,102697,102565,632565,632556,524556,524175,776180,97190,60790,60788,04388,04360,04560,04553,69353,69337,52937,52940,19740,58530,44130,44130,56930,56915,50125,416
   > Total Current Assets 
2,166
2,166
7,006
7,006
4,958
4,958
13,400
13,400
14,472
14,472
15,500
15,500
8,099
8,099
18,026
18,026
17,187
17,187
37,264
37,264
83,957
83,957
103,106
103,106
98,347
98,347
101,872
103,105
107,303
107,303
100,870
100,870
93,182
93,182
93,18293,182100,870100,870107,303107,303103,105101,87298,34798,347103,106103,10683,95783,95737,26437,26417,18717,18718,02618,0268,0998,09915,50015,50014,47214,47213,40013,4004,9584,9587,0067,0062,1662,166
       Cash And Cash Equivalents 
182
182
2,850
2,850
1,104
1,104
9,268
9,268
10,036
10,036
9,763
9,763
1,320
1,320
8,329
8,329
8,175
8,175
17,476
17,476
18,095
18,095
35,126
35,126
35,598
35,598
34,295
34,295
19,840
19,840
41,829
41,829
12,081
12,081
12,08112,08141,82941,82919,84019,84034,29534,29535,59835,59835,12635,12618,09518,09517,47617,4768,1758,1758,3298,3291,3201,3209,7639,76310,03610,0369,2689,2681,1041,1042,8502,850182182
       Short-term Investments 
50
99
56
179
56
177
7
142
9
397
84
151
84
151
88
439
88
575
152
129
117
272
103
5,441
358
358
1,769
1,549
401
401
554
348
10,960
724
72410,9603485544014011,5491,7693583585,441103272117129152575884398815184151843979142717756179569950
       Net Receivables 
1,412
1,412
2,721
2,721
2,601
3,498
3,368
3,368
3,351
3,837
3,717
4,939
4,984
6,246
8,289
9,131
6,613
6,613
16,985
19,005
56,863
60,770
54,295
56,636
52,721
57,631
55,301
60,767
64,712
69,541
44,626
50,582
0
59,537
59,537050,58244,62669,54164,71260,76755,30157,63152,72156,63654,29560,77056,86319,00516,9856,6136,6139,1318,2896,2464,9844,9393,7173,8373,3513,3683,3683,4982,6012,7212,7211,4121,412
       Inventory 
169
169
182
181
237
178
211
208
211
211
259
259
259
259
271
271
493
493
655
655
731
731
793
793
936
936
1,213
1,213
1,571
1,571
1,677
1,677
1,577
1,577
1,5771,5771,6771,6771,5711,5711,2131,213936936793793731731655655493493271271259259259259211211208211178237181182169169
       Other Current Assets 
403
403
1,196
1,196
959
0
546
546
864
388
1,677
471
1,452
206
1,048
226
1,817
1,817
1,996
0
8,151
4,361
12,789
3,978
8,734
4,182
9,294
6,830
20,779
16,351
12,184
6,782
68,564
17,627
17,62768,5646,78212,18416,35120,7796,8309,2944,1828,7343,97812,7894,3618,15101,9961,8171,8172261,0482061,4524711,67738886454654609591,1961,196403403
   > Long-term Assets 
23,250
23,250
23,564
23,564
25,484
25,484
27,184
26,797
23,058
23,058
38,193
38,193
51,946
51,946
70,017
70,017
73,420
73,420
143,707
138,512
472,567
472,567
462,526
462,526
598,755
598,755
602,176
602,176
588,174
588,174
528,131
528,131
509,881
509,881
509,881509,881528,131528,131588,174588,174602,176602,176598,755598,755462,526462,526472,567472,567138,512143,70773,42073,42070,01770,01751,94651,94638,19338,19323,05823,05826,79727,18425,48425,48423,56423,56423,25023,250
       Property Plant Equipment 
2,970
2,970
2,755
2,755
2,708
2,708
2,571
2,571
2,933
2,415
3,089
2,648
4,093
3,394
7,585
5,738
10,112
8,531
12,328
9,843
63,702
43,643
62,538
62,538
64,208
64,208
69,331
69,331
65,112
65,112
62,479
62,479
59,637
59,637
59,63759,63762,47962,47965,11265,11269,33169,33164,20864,20862,53862,53843,64363,7029,84312,3288,53110,1125,7387,5853,3944,0932,6483,0892,4152,9332,5712,5712,7082,7082,7552,7552,9702,970
       Goodwill 
1,841
1,841
1,744
1,744
1,648
1,648
1,938
1,550
1,938
1,938
10,095
10,095
21,159
21,159
35,460
35,460
35,460
35,460
71,490
95,051
249,259
249,259
235,836
235,836
304,154
304,154
306,212
306,212
305,847
305,847
275,740
275,740
273,532
273,532
273,532273,532275,740275,740305,847305,847306,212306,212304,154304,154235,836235,836249,259249,25995,05171,49035,46035,46035,46035,46021,15921,15910,09510,0951,9381,9381,5501,9381,6481,6481,7441,7441,8411,841
       Intangible Assets 
13,437
13,437
716
13,649
749
14,289
984
15,177
825
10,428
1,122
17,009
1,269
17,911
1,412
19,542
1,404
19,786
30,131
26,482
122,638
165,820
127,611
151,132
192,225
215,918
187,855
212,690
173,593
198,326
149,307
174,745
161,073
143,099
143,099161,073174,745149,307198,326173,593212,690187,855215,918192,225151,132127,611165,820122,63826,48230,13119,7861,40419,5421,41217,9111,26917,0091,12210,42882515,17798414,28974913,64971613,43713,437
       Other Assets 
4,945
-9,915
18,271
0
19,571
0
21,604
0
17,274
0
23,787
0
25,278
0
25,526
0
26,410
0
29,661
28,447
34,675
0
35,737
35,737
37,279
37,279
37,839
8,874
43,528
43,528
0
0
0
0
000043,52843,5288,87437,83937,27937,27935,73735,737034,67528,44729,661026,410025,526025,278023,787017,274021,604019,571018,271-9,9154,945
> Total Liabilities 
15,501
15,501
16,306
16,306
16,146
16,146
21,634
16,899
14,071
14,071
27,250
27,250
33,293
33,293
48,089
48,089
51,509
51,509
109,591
100,448
270,972
270,972
291,653
291,653
352,991
352,991
367,708
367,708
377,587
377,587
339,119
332,457
331,966
331,966
331,966331,966332,457339,119377,587377,587367,708367,708352,991352,991291,653291,653270,972270,972100,448109,59151,50951,50948,08948,08933,29333,29327,25027,25014,07114,07116,89921,63416,14616,14616,30616,30615,50115,501
   > Total Current Liabilities 
2,933
2,933
4,369
4,369
4,004
4,004
5,259
4,966
3,875
3,875
5,480
5,480
10,970
10,970
9,819
9,819
11,407
11,407
21,410
21,410
67,075
67,075
71,502
71,502
84,825
84,825
100,563
100,563
110,425
110,425
103,642
103,642
95,195
95,195
95,19595,195103,642103,642110,425110,425100,563100,56384,82584,82571,50271,50267,07567,07521,41021,41011,40711,4079,8199,81910,97010,9705,4805,4803,8753,8754,9665,2594,0044,0044,3694,3692,9332,933
       Short-term Debt 
905
909
3,193
3,242
2,772
2,802
2,852
1,152
2,342
1,007
2,833
3,024
5,887
6,147
4,912
4,486
6,683
7,197
11,109
11,822
17,797
22,847
15,518
25,586
25,397
31,297
23,364
48,255
39,040
44,737
57,869
64,311
14,827
47,356
47,35614,82764,31157,86944,73739,04048,25523,36431,29725,39725,58615,51822,84717,79711,82211,1097,1976,6834,4864,9126,1475,8873,0242,8331,0072,3421,1522,8522,8022,7723,2423,193909905
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,501
0
11,082
0
17,797
0
15,518
0
25,397
0
23,364
0
39,040
0
57,869
0
0
0057,869039,040023,364025,397015,518017,797011,08206,50100000000000000000
       Accounts payable 
768
364
925
626
953
619
1,531
970
1,028
1,064
1,194
798
1,962
1,435
1,786
2,000
1,652
907
4,255
4,255
14,553
10,467
10,365
10,365
11,825
11,825
15,686
15,686
18,414
18,414
19,136
19,136
19,880
19,880
19,88019,88019,13619,13618,41418,41415,68615,68611,82511,82510,36510,36510,46714,5534,2554,2559071,6522,0001,7861,4351,9627981,1941,0641,0289701,531619953626925364768
       Other Current Liabilities 
1,260
2,165
251
0
278
3,051
877
3,728
506
1,541
1,452
298
3,122
283
3,120
268
3,071
256
6,046
310
34,725
300
45,619
294
47,603
294
61,513
294
52,971
410
26,637
20,009
60,488
27,496
27,49660,48820,00926,63741052,97129461,51329447,60329445,61930034,7253106,0462563,0712683,1202833,1222981,4521,5415063,7288773,05127802512,1651,260
   > Long-term Liabilities 
12,568
12,568
11,937
11,937
12,143
12,143
16,374
11,933
10,195
10,195
21,771
21,771
22,322
22,322
38,270
38,270
40,102
40,102
88,181
79,038
203,897
203,897
220,151
220,151
268,166
268,166
267,145
267,145
267,162
267,162
235,477
228,815
236,771
236,771
236,771236,771228,815235,477267,162267,162267,145267,145268,166268,166220,151220,151203,897203,89779,03888,18140,10240,10238,27038,27022,32222,32221,77121,77110,19510,19511,93316,37412,14312,14311,93711,93712,56812,568
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
136,597
0
171,706
0
172,341
0
0
0
0
0
0
000000172,3410171,7060136,59700000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,101
8,101
8,194
8,194
19,465
19,465
41,851
41,851
41,283
41,283
57,767
57,767
56,730
56,730
53,218
53,218
0
0
0
0
000053,21853,21856,73056,73057,76757,76741,28341,28341,85141,85119,46519,4658,1948,1948,1018,10100000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,284
16,284
16,801
16,801
21,407
21,407
23,122
23,122
23,521
23,521
23,693
23,693
24,835
24,835
24,733
24,733
0
0
0
0
000024,73324,73324,83524,83523,69323,69323,52123,52123,12223,12221,40721,40716,80116,80116,28416,28400000000000000
> Total Stockholder Equity
9,915
2,540
14,263
14,263
14,295
14,295
18,951
23,298
23,459
23,459
26,443
26,443
26,752
26,752
39,954
39,954
39,098
39,098
71,380
75,328
285,552
285,552
274,030
274,030
344,149
344,149
336,397
337,630
318,093
318,093
289,872
289,872
271,193
271,193
271,193271,193289,872289,872318,093318,093337,630336,397344,149344,149274,030274,030285,552285,55275,32871,38039,09839,09839,95439,95426,75226,75226,44326,44323,45923,45923,29818,95114,29514,29514,26314,2632,5409,915
   Common Stock
81
81
112
112
112
112
176
176
204
204
216
216
216
216
256
256
256
256
347
347
612
612
614
614
736
736
760
760
760
760
760
760
760
760
7607607607607607607607607367366146146126123473472562562562562162162162162042041761761121121121128181
   Retained Earnings 
2,459
398
1,302
63
1,364
96
1,392
97
1,813
239
1,562
12
1,709
129
-105
-105
-849
-849
-5,548
-2,015
-3,313
-3,313
-23,255
-23,255
-3,166
-3,166
-68,886
-23,259
-65,260
-23,004
-87,861
-45,590
-16,479
-77,957
-77,957-16,479-45,590-87,861-23,004-65,260-23,259-68,886-3,166-3,166-23,255-23,255-3,313-3,313-2,015-5,548-849-849-105-1051291,709121,5622391,813971,392961,364631,3023982,459
   Accumulated Other Comprehensive Income 
3,129
3,129
4,560
4,560
4,584
4,584
145
145
-10
1,803
-10
1,552
75
1,784
1,525
1,420
1,427
1,427
-1,444
-1,444
-25,689
-29,176
-18,355
-18,355
-58,663
-61,829
-14,780
-82,433
-36,611
-101,871
-42,787
-130,648
-132,868
-71,390
-71,390-132,868-130,648-42,787-101,871-36,611-82,433-14,780-61,829-58,663-18,355-18,355-29,176-25,689-1,444-1,4441,4271,4271,4201,5251,784751,552-101,803-101451454,5844,5844,5604,5603,1293,129
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
315,501
0
405,277
0
420,053
0
0
0
0
0
0
000000420,0530405,2770315,50100000000000000000000000
   Treasury Stock0000000000000000000000000000000000
   Other Stockholders Equity 
4,245
-1,068
8,289
9,528
8,235
9,503
17,237
22,879
21,452
21,213
24,676
24,664
24,753
24,624
38,278
38,383
38,264
38,264
78,025
76,996
313,941
288,252
315,026
22,641
405,242
2,430
419,303
22,499
419,204
340,337
419,760
420,520
419,780
404,061
404,061419,780420,520419,760340,337419,20422,499419,3032,430405,24222,641315,026288,252313,94176,99678,02538,26438,26438,38338,27824,62424,75324,66424,67621,21321,45222,87917,2379,5038,2359,5288,289-1,0684,245



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue201,569
Cost of Revenue-170,027
Gross Profit31,54231,542
 
Operating Income (+$)
Gross Profit31,542
Operating Expense-27,748
Operating Income3,7943,794
 
Operating Expense (+$)
Research Development3,116
Selling General Administrative6,089
Selling And Marketing Expenses785
Operating Expense27,7489,990
 
Net Interest Income (+$)
Interest Income627
Interest Expense-33,047
Other Finance Cost-0
Net Interest Income-32,420
 
Pretax Income (+$)
Operating Income3,794
Net Interest Income-32,420
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-30,80638,394
EBIT - interestExpense = -29,253
-45,641
-12,543
Interest Expense33,047
Earnings Before Interest and Taxes (EBIT)3,7942,241
Earnings Before Interest and Taxes (EBITDA)33,467
 
After tax Income (+$)
Income Before Tax-30,806
Tax Provision--2,941
Net Income From Continuing Ops-30,755-27,865
Net Income-45,590
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses197,775
Total Other Income/Expenses Net-34,60032,420
 

Technical Analysis of Atrys Health SL
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Atrys Health SL. The general trend of Atrys Health SL is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Atrys Health SL's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Atrys Health SL.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 3.05 < 3.79 < 3.95.

The bearish price targets are: 3.02 > 3 > 3.

Tweet this
Atrys Health SL Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Atrys Health SL. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Atrys Health SL Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Atrys Health SL. The current macd is -0.0531478.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Atrys Health SL price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Atrys Health SL. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Atrys Health SL price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Atrys Health SL Daily Moving Average Convergence/Divergence (MACD) ChartAtrys Health SL Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Atrys Health SL. The current adx is 14.30.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Atrys Health SL shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Atrys Health SL Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Atrys Health SL. The current sar is 3.31181593.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Atrys Health SL Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Atrys Health SL. The current rsi is 36.60. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Atrys Health SL Daily Relative Strength Index (RSI) ChartAtrys Health SL Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Atrys Health SL. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Atrys Health SL price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Atrys Health SL Daily Stochastic Oscillator ChartAtrys Health SL Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Atrys Health SL. The current cci is -112.3388582.

The long score f